SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Seelaus Asset Management LLC

Seelaus Asset Management LLC lessened its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 27.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,663 shares of the exchange traded fund’s stock after selling 1,359 shares during the period. Seelaus Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $330,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in XBI. Hartline Investment Corp boosted its holdings in shares of SPDR S&P Biotech ETF by 2.0% in the 3rd quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock valued at $544,000 after buying an additional 106 shares in the last quarter. Signature Estate & Investment Advisors LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 5.7% in the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock valued at $231,000 after buying an additional 125 shares in the last quarter. Denver Wealth Management Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 0.9% in the 3rd quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock valued at $1,460,000 after buying an additional 127 shares in the last quarter. Trust Co. of Vermont boosted its holdings in shares of SPDR S&P Biotech ETF by 4.7% in the 3rd quarter. Trust Co. of Vermont now owns 3,058 shares of the exchange traded fund’s stock valued at $302,000 after buying an additional 138 shares in the last quarter. Finally, Graypoint LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 5.6% in the 3rd quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock valued at $271,000 after buying an additional 146 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 2.3 %

Shares of SPDR S&P Biotech ETF stock opened at $91.24 on Friday. The company has a fifty day simple moving average of $92.58 and a 200-day simple moving average of $96.48. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The stock has a market cap of $6.95 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.